FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1837134848> ?p ?o ?g. }

• W1837134848 endingPage "4172" @default.
• W1837134848 startingPage "4165" @default.
• W1837134848 abstract "Treatment options for patients with non-small cell lung cancer (NSCLC) with brain metastases are limited. Patupilone (EPO906), a blood-brain barrier-penetrating, microtubule-targeting, cytotoxic agent, has shown clinical activity in phase 1/2 studies in patients with NSCLC. This study evaluates the efficacy, pharmacokinetics, and safety of patupilone in NSCLC brain metastases.Adult patients with NSCLC and confirmed progressive brain metastases received patupilone intravenously at 10 mg/m(2) every 3 weeks. The primary endpoint of this multinomial 2-stage study combined early progression (EP; death or progression within 3 weeks) and progression-free survival at 9 weeks (PFS9w) to determine drug activity.Fifty patients with a median age of 60 years (range, 33-74 years) were enrolled; the majority were men (58%), and most had received prior therapy for brain metastases (98%). The PFS9w rate was 36%, and the EP rate was 26%. Patupilone blood pharmacokinetic analyses showed mean areas under the concentration-time curve from time zero to 504 hours for cycles 1 and 3 of 1544 and 1978 ng h/mL, respectively, and a mean steady state distribution volume of 755 L/m(2) . Grade 3/4 adverse events (AEs), regardless of their relation with the study drug, included diarrhea (24%), pulmonary embolisms (8%), convulsions (4%), and peripheral neuropathy (4%). All patients discontinued the study drug: 31 (62%) for disease progression and 13 (26%) for AEs. Twenty-five of 32 deaths were due to brain metastases. The median time to progression and the overall survival were 3.2 and 8.8 months, respectively.This is the first prospective study of chemotherapy for recurrent brain metastases from NSCLC. In this population, patupilone demonstrated activity in heavily treated patients." @default.
• W1837134848 created "2016-06-24" @default.
• W1837134848 creator A5003825991 @default.
• W1837134848 creator A5013091949 @default.
• W1837134848 creator A5014122300 @default.
• W1837134848 creator A5018451725 @default.
• W1837134848 creator A5020397680 @default.
• W1837134848 creator A5020641571 @default.
• W1837134848 creator A5021656597 @default.
• W1837134848 creator A5025836672 @default.
• W1837134848 creator A5033270808 @default.
• W1837134848 creator A5068824818 @default.
• W1837134848 creator A5070190752 @default.
• W1837134848 creator A5074789425 @default.
• W1837134848 creator A5075490964 @default.
• W1837134848 creator A5084965180 @default.
• W1837134848 creator A5089417324 @default.
• W1837134848 date "2015-08-26" @default.
• W1837134848 modified "2023-10-16" @default.
• W1837134848 title "Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer" @default.
• W1837134848 cites W1534608409 @default.
• W1837134848 cites W1588607955 @default.
• W1837134848 cites W1932428064 @default.
• W1837134848 cites W1971423558 @default.
• W1837134848 cites W1973944247 @default.
• W1837134848 cites W1974820090 @default.
• W1837134848 cites W1999896690 @default.
• W1837134848 cites W2010619956 @default.
• W1837134848 cites W2013614225 @default.
• W1837134848 cites W2016908822 @default.
• W1837134848 cites W2025208846 @default.
• W1837134848 cites W2031924229 @default.
• W1837134848 cites W2032174366 @default.
• W1837134848 cites W2040561412 @default.
• W1837134848 cites W2053857197 @default.
• W1837134848 cites W2055038110 @default.
• W1837134848 cites W2057864075 @default.
• W1837134848 cites W2059857815 @default.
• W1837134848 cites W2074887877 @default.
• W1837134848 cites W2075677078 @default.
• W1837134848 cites W2085678636 @default.
• W1837134848 cites W2089588020 @default.
• W1837134848 cites W2096557421 @default.
• W1837134848 cites W2103451990 @default.
• W1837134848 cites W2104966951 @default.
• W1837134848 cites W2114464493 @default.
• W1837134848 cites W2126799977 @default.
• W1837134848 cites W2128688922 @default.
• W1837134848 cites W2129455899 @default.
• W1837134848 cites W2129559903 @default.
• W1837134848 cites W2139060364 @default.
• W1837134848 cites W2140301973 @default.
• W1837134848 cites W2155553418 @default.
• W1837134848 cites W2157342168 @default.
• W1837134848 cites W2160069052 @default.
• W1837134848 cites W2162065895 @default.
• W1837134848 cites W2162934203 @default.
• W1837134848 cites W2171136529 @default.
• W1837134848 cites W2247794300 @default.
• W1837134848 doi "https://doi.org/10.1002/cncr.29636" @default.
• W1837134848 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5941922" @default.
• W1837134848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26308485" @default.
• W1837134848 hasPublicationYear "2015" @default.
• W1837134848 type Work @default.
• W1837134848 sameAs 1837134848 @default.
• W1837134848 citedByCount "14" @default.
• W1837134848 countsByYear W18371348482016 @default.
• W1837134848 countsByYear W18371348482017 @default.
• W1837134848 countsByYear W18371348482018 @default.
• W1837134848 countsByYear W18371348482019 @default.
• W1837134848 countsByYear W18371348482020 @default.
• W1837134848 countsByYear W18371348482021 @default.
• W1837134848 countsByYear W18371348482023 @default.
• W1837134848 crossrefType "journal-article" @default.
• W1837134848 hasAuthorship W1837134848A5003825991 @default.
• W1837134848 hasAuthorship W1837134848A5013091949 @default.
• W1837134848 hasAuthorship W1837134848A5014122300 @default.
• W1837134848 hasAuthorship W1837134848A5018451725 @default.
• W1837134848 hasAuthorship W1837134848A5020397680 @default.
• W1837134848 hasAuthorship W1837134848A5020641571 @default.
• W1837134848 hasAuthorship W1837134848A5021656597 @default.
• W1837134848 hasAuthorship W1837134848A5025836672 @default.
• W1837134848 hasAuthorship W1837134848A5033270808 @default.
• W1837134848 hasAuthorship W1837134848A5068824818 @default.
• W1837134848 hasAuthorship W1837134848A5070190752 @default.
• W1837134848 hasAuthorship W1837134848A5074789425 @default.
• W1837134848 hasAuthorship W1837134848A5075490964 @default.
• W1837134848 hasAuthorship W1837134848A5084965180 @default.
• W1837134848 hasAuthorship W1837134848A5089417324 @default.
• W1837134848 hasBestOaLocation W18371348481 @default.
• W1837134848 hasConcept C112705442 @default.
• W1837134848 hasConcept C121608353 @default.
• W1837134848 hasConcept C126322002 @default.
• W1837134848 hasConcept C126894567 @default.
• W1837134848 hasConcept C143998085 @default.
• W1837134848 hasConcept C197934379 @default.
• W1837134848 hasConcept C203092338 @default.
• W1837134848 hasConcept C2776256026 @default.

• next